Cohen José E, Gomori John Moshe, Rajz Gustavo, Paldor Iddo, Moscovici Samuel, Itshayek Eyal
Department of Neurosurgery, Hadassah-Hebrew University Medical Center, POB 12000, Jerusalem, Israel, 91120.
Department of Radiology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
Acta Neurochir (Wien). 2017 May;159(5):845-853. doi: 10.1007/s00701-017-3089-0. Epub 2017 Jan 31.
Galenic dural arteriovenous fistulas (DAVF) are rare; however, they are the most frequent type of DAVF to manifest aggressive clinical behavior and usually represent a diagnostic and therapeutic challenge for clinicians.
We retrospectively reviewed clinical and imaging data of patients managed with neuroendovascular techniques for the treatment of galenic DAVFs from 2000 to 2016. We searched the 2000-2016 English-language literature for papers discussing neuroendovascular management of galenic DAVFs, with or without companion surgical procedures.
Five patients were treated for galenic DAVFs during the study period (four males; mean age, 61 years). Three presented with progressive neurological deterioration due to venous congestion, two with acute intracranial hemorrhage. Three were treated by staged transarterial embolization procedures (three procedures in two, four procedures in one); two underwent a single transvenous embolization procedure. Four out of five fistulas were completely occluded. All patients improved clinically; the patient whose fistula was partially occluded remains angiographically stable at 2-year follow-up. Six reports describing 17 patients are reviewed. Embolization was performed via transvenous approach in 1/17 and transarterial approach in 16/17 with additional open surgery in 9/16. The trend toward the use of transarterial approaches is based primarily on advances on embolization techniques that allow better and more controllable penetration of the embolizing agents with improved clinical and angiographic results, as well as the technical complexity of the transvenous approach.
Although transarterial embolization is the preferred endovascular route for the management of most galenic DAVFs, selected cases can be successfully treated by transvenous approach.
盖伦静脉型硬脑膜动静脉瘘(DAVF)较为罕见;然而,它们是表现出侵袭性临床行为的最常见的DAVF类型,通常对临床医生构成诊断和治疗挑战。
我们回顾性分析了2000年至2016年采用神经血管内技术治疗盖伦静脉型DAVF患者的临床和影像学资料。我们检索了2000 - 2016年的英文文献,查找讨论盖伦静脉型DAVF神经血管内治疗的论文,无论是否伴有手术治疗。
在研究期间,5例患者接受了盖伦静脉型DAVF治疗(4例男性;平均年龄61岁)。3例因静脉淤血出现进行性神经功能恶化,2例发生急性颅内出血。3例接受分期经动脉栓塞治疗(2例进行了3次操作,1例进行了4次操作);2例接受了单次经静脉栓塞治疗。5例瘘管中有4例完全闭塞。所有患者临床症状均有改善;瘘管部分闭塞的患者在2年随访时血管造影显示稳定。回顾了6篇描述17例患者的报告。17例中1例经静脉途径进行栓塞,16例经动脉途径进行栓塞,其中9例联合了开放手术。采用经动脉途径的趋势主要基于栓塞技术的进步,这些技术能够使栓塞剂更好、更可控地渗透,从而改善临床和血管造影结果,以及经静脉途径的技术复杂性。
尽管经动脉栓塞是大多数盖伦静脉型DAVF血管内治疗的首选途径,但部分病例经静脉途径也可成功治疗。